ATRC
AtriCure's Q2 Earnings Exceed Expectations, Driven by Strong Franchise Growth and Clinical Trial Progress
AtriCure, a leading medical technology company, recently announced its Q2 2026 earnings results, exceeding expectations with worldwide revenue of $154 million and growth of 13%. According to Michael Carrel, President and CEO, the U.S. business led the growth with an increase of 14% year-over-year, fueled by continued adoption of